BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Home
»
Authors
» Trista Morrison
Trista Morrison
Articles
ARTICLES
Elixir Raises $46M Series C For Metabolic Disease Trials
Nov. 29, 2006
By
Trista Morrison
Orexigen Closes $30M Round For Late-Stage Obesity Trials
Nov. 27, 2006
By
Trista Morrison
Orexigen Closes $30M Round For Late-Stage Obesity Trials
Nov. 27, 2006
By
Trista Morrison
Intradigm Raises $16M For Systemic Delivery Of RNAi
Nov. 22, 2006
By
Trista Morrison
Intradigm Raises $16M For Systemic Delivery Of RNAi
Nov. 22, 2006
By
Trista Morrison
Neurotech Brings In $35M For Phase II Retinal Disease Trials
Nov. 17, 2006
By
Trista Morrison
Neurotech Brings In $35M For Phase II Retinal Disease Trials
Nov. 17, 2006
By
Trista Morrison
Biotech's Business Models Evolve As Industry Matures
Nov. 16, 2006
By
Trista Morrison
Biotech's Business Models Evolve As Industry Matures
Nov. 16, 2006
By
Trista Morrison
Sofinnova Closes $375M Fund To Support Spinouts
Nov. 15, 2006
By
Trista Morrison
View All Articles by Trista Morrison
